In situ gastrointestinal protection against anthrax edema toxin by single-chain antibody fragment producing lactobacilli

BMC Biotechnology

Volumn 11, Issue , 2011, Pages

  Andersen, Kasper K ^a   Marcotte, Harold ^a   Álvarez, Beatriz ^a   Boyaka, Prosper N ^b   Hammarström, Lennart ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXINS; ANTIBODY FRAGMENT; BACILLUS ANTHRACIS; CELL WALLS; EDEMA FACTORS; FLOW CYTOMETRY ANALYSIS; GASTROINTESTINAL TRACT; GI TRACT; IN-SITU; IN-VITRO; LETHAL FACTOR; MODEL SYSTEM; NEUTRALISATION; PROTECTIVE ANTIGENS; RECEPTOR BINDING; RECOMBINANT ANTIBODY; ROTAVIRUSES; SECRETED PROTEIN; SINGLE-CHAIN ANTIBODIES; STREPTOCOCCUS MUTANS;

ANTIBODIES; ANTIGENS; DISEASES; METABOLITES; RECOMBINANT PROTEINS; TOXIC MATERIALS;

BACILLI;

ANTHRAX TOXIN; NEUTRALIZING ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; BACTERIAL ANTIGEN; BACTERIAL TOXIN; BACTERIUM ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL CELL WALL; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL EDEMA; GASTROINTESTINAL TRACT; GENE CONSTRUCT; IN VITRO STUDY; LACTOBACILLUS PARACASEI; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; ANIMAL; ANTHRAX; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; GENETIC ENGINEERING; GENETICS; IMMUNOLOGY; LACTOBACILLUS; MICROBIOLOGY; PLASMID;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS); MUS; PORPHYROMONAS GINGIVALIS; ROTAVIRUS; STREPTOCOCCUS MUTANS;

ANIMALS; ANTHRAX; ANTIBODIES, BACTERIAL; ANTIBODIES, NEUTRALIZING; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; CELL LINE; FEMALE; GASTROINTESTINAL TRACT; GENETIC ENGINEERING; LACTOBACILLUS; MACROPHAGES; MICE; MICE, INBRED C57BL; PLASMIDS; SINGLE-CHAIN ANTIBODIES;

EID: 84857916544     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-11-126     Document Type: Article

References (39)

1. Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Gerberding J, Hauer J, Hughes J, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. Jama 2002, 287(17):2236-2252. 10.1001/jama.287.17.2236, 11980524.
2. Torok TJ, Tauxe RV, Wise RP, Livengood JR, Sokolow R, Mauvais S, Birkness KA, Skeels MR, Horan JM, Foster LR. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. Jama 1997, 278(5):389-395. 10.1001/jama.1997.03550050051033, 9244330.
3. Harris S. Japanese biological warfare research on humans: a case study of microbiology and ethics. Ann N Y Acad Sci 1992, 666:21-52. 10.1111/j.1749-6632.1992.tb38021.x, 1297279.
4. Daley S. In support of appartheid: poison whisky and sterilisation. New York Times 1998, June 11, Section A.
5. Glomski IJ, Piris-Gimenez A, Huerre M, Mock M, Goossens PL. Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax. PLoS Pathog 2007, 3(6):e76. 10.1371/journal.ppat.0030076, 1885272, 17542645.
6. Beatty ME, Ashford DA, Griffin PM, Tauxe RV, Sobel J. Gastrointestinal anthrax: review of the literature. Arch Intern Med 2003, 163(20):2527-2531. 10.1001/archinte.163.20.2527, 14609791.
7. Abrami L, Reig N, van der Goot FG. Anthrax toxin: the long and winding road that leads to the kill. Trends Microbiol 2005, 13(2):72-78. 10.1016/j.tim.2004.12.004, 15680766.
8. Scobie HM, Young JA. Interactions between anthrax toxin receptors and protective antigen. Curr Opin Microbiol 2005, 8(1):106-112. 10.1016/j.mib.2004.12.005, 15694864.
9. van der Goot G, Young JA. Receptors of anthrax toxin and cell entry. Mol Aspects Med 2009, 30(6):406-412. 10.1016/j.mam.2009.08.007, 2783407, 19732789.
10. Duesbery NS, Webb CP, Leppla SH, Gordon VM, Klimpel KR, Copeland TD, Ahn NG, Oskarsson MK, Fukasawa K, Paull KD, et al. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 1998, 280(5364):734-737. 10.1126/science.280.5364.734, 9563949.
11. Moayeri M, Haines D, Young HA, Leppla SH. Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J Clin Invest 2003, 112(5):670-682. 182199, 12952916.
12. Leppla SH. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci USA 1982, 79(10):3162-3166. 10.1073/pnas.79.10.3162, 346374, 6285339.
13. Firoved AM, Miller GF, Moayeri M, Kakkar R, Shen Y, Wiggins JF, McNally EM, Tang WJ, Leppla SH. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am J Pathol 2005, 167(5):1309-1320. 10.1016/S0002-9440(10)61218-7, 1603774, 16251415.
14. Leysath CE, Monzingo AF, Maynard JA, Barnett J, Georgiou G, Iverson BL, Robertus JD. Crystal structure of the engineered neutralizing antibody M18 complexed to domain 4 of the anthrax protective antigen. J Mol Biol 2009, 387(3):680-693. 10.1016/j.jmb.2009.02.003, 2670345, 19361425.
15. Little SF, Leppla SH, Cora E. Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin. Infect Immun 1988, 56(7):1807-1813. 259481, 3384478.
16. Pittman PR, Gibbs PH, Cannon TL, Friedlander AM. Anthrax vaccine: short-term safety experience in humans. Vaccine 2001, 20(5-6):972-978. 10.1016/S0264-410X(01)00387-5, 11738765.
17. Fowler RA, Sanders GD, Bravata DM, Nouri B, Gastwirth JM, Peterson D, Broker AG, Garber AM, Owens DK. Cost-effectiveness of defending against bioterrorism: a comparison of vaccination and antibiotic prophylaxis against anthrax. Ann Intern Med 2005, 142(8):601-610.
18. Webb GF. Being prepared: modeling the response to an anthrax attack. Ann Intern Med 2005, 142(8):667-668.
19. Klinman DM, Tross D. A single-dose combination therapy that both prevents and treats anthrax infection. Vaccine 2009, 27(12):1811. 10.1016/j.vaccine.2009.01.094, 19402202.
20. Manson JM, Rauch M, Gilmore MS. The commensal microbiology of the gastrointestinal tract. Adv Exp Med Biol 2008, 635:15-28. 10.1007/978-0-387-09550-9_2, 18841700.
21. Wells JM, Mercenier A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 2008, 6(5):349-362. 10.1038/nrmicro1840, 18345021.
22. Pant N, Hultberg A, Zhao Y, Svensson L, Pan-Hammarstrom Q, Johansen K, Pouwels PH, Ruggeri FM, Hermans P, Frenken L, et al. Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea. J Infect Dis 2006, 194(11):1580-1588. 10.1086/508747, 17083044.
23. Kruger C, Hu Y, Pan Q, Marcotte H, Hultberg A, Delwar D, van Dalen PJ, Pouwels PH, Leer RJ, Kelly CG, et al. In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat Biotechnol 2002, 20(7):702-706. 10.1038/nbt0702-702, 12089555.
24. Maynard JA, Maassen CB, Leppla SH, Brasky K, Patterson JL, Iverson BL, Georgiou G. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity. Nat Biotechnol 2002, 20(6):597-601. 10.1038/nbt0602-597, 12042864.
25. Martin MC, Pant N, Ladero V, Gunaydin G, Andersen KK, Alvarez B, Martinez N, Alvarez MA, Hammarstrom L, Marcotte H. Integrative expression system for delivery of antibody fragments by lactobacilli. Appl Environ Microbiol 2011, 77(6):2174-2179. 10.1128/AEM.02690-10, 3067310, 21257814.
26. Turner MS, Hafner LM, Walsh T, Giffard PM. Identification and characterization of the novel LysM domain-containing surface protein Sep from Lactobacillus fermentum BR11 and its use as a peptide fusion partner in Lactobacillus and Lactococcus. Appl Environ Microbiol 2004, 70(6):3673-3680. 10.1128/AEM.70.6.3673-3680.2004, 427774, 15184172.
27. Marcotte H, Ferrari S, Cesena C, Hammarstrom L, Morelli L, Pozzi G, Oggioni MR. The aggregation-promoting factor of Lactobacillus crispatus M247 and its genetic locus. J Appl Microbiol 2004, 97(4):749-756. 10.1111/j.1365-2672.2004.02364.x, 15357724.
28. Miller BR, Demarest SJ, Lugovskoy A, Huang F, Wu X, Snyder WB, Croner LJ, Wang N, Amatucci A, Michaelson JS, et al. Stability engineering of scFvs for the development of bispecific and multivalent antibodies. Protein Eng Des Sel 2010, 23(7):549-557. 10.1093/protein/gzq028, 20457695.
29. Worn A, Pluckthun A. Stability engineering of antibody single-chain Fv fragments. J Mol Biol 2001, 305(5):989-1010. 10.1006/jmbi.2000.4265, 11162109.
30. Mohamadzadeh M, Duong T, Sandwick SJ, Hoover T, Klaenhammer TR. Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge. Proc Natl Acad Sci USA 2009, 106(11):4331-4336. 10.1073/pnas.0900029106, 2647975, 19246373.
31. Hussack G, Arbabi-Ghahroudi M, van Faassen H, Songer JG, Ng KK, MacKenzie R, Tanha J. Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain. J Biol Chem 2011, 286(11):8961-8976.
32. Acedo-Felix E, Perez-Martinez G. Significant differences between Lactobacillus casei subsp. casei ATCC 393T and a commonly used plasmid-cured derivative revealed by a polyphasic study. Int J Syst Evol Microbiol 2003, 53(Pt 1):67-75.
33. Marcotte H, Koll-Klais P, Hultberg A, Zhao Y, Gmur R, Mandar R, Mikelsaar M, Hammarstrom L. Expression of single-chain antibody against RgpA protease of Porphyromonas gingivalis in Lactobacillus. J Appl Microbiol 2006, 100(2):256-263. 10.1111/j.1365-2672.2005.02786.x, 16430501.
34. Perez-Arellano I, Zuniga M, Perez-Martinez G. Construction of compatible wide-host-range shuttle vectors for lactic acid bacteria and Escherichia coli. Plasmid 2001, 46(2):106-116. 10.1006/plas.2001.1531, 11591136.
35. Schmiedl A, Breitling F, Winter CH, Queitsch I, Dubel S. Effects of unpaired cysteines on yield, solubility and activity of different recombinant antibody constructs expressed in E. coli. J Immunol Methods 2000, 242(1-2):101-114. 10.1016/S0022-1759(00)00243-X, 10986393.
36. Singh Y, Leppla SH, Bhatnagar R, Friedlander AM. Internalization and processing of Bacillus anthracis lethal toxin by toxin-sensitive and -resistant cells. J Biol Chem 1989, 264(19):11099-11102.
37. Hanna PC, Kochi S, Collier RJ. Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells. Mol Biol Cell 1992, 3(11):1269-1277. 275693, 1457831.
38. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65(1-2):55-63. 10.1016/0022-1759(83)90303-4, 6606682.
39. Møretrø T, Hagen BF, Axelsson L. A new, completely defined medium for meat lactobacilli. Journal of Applied Microbiology 1998, 85:715-722.